NCT07281976 2026-02-12A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast CancerNanjing Leads Biolabs Co.,LtdPhase 1/2 Recruiting220 enrolled
NCT04213898 2019-12-30SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast CancerHenan Cancer HospitalPhase 1/2 Unknown39 enrolled